Search

Search Constraints

You searched for: Author/Creator Marschalko, M.

Search Results

1. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (1st March 2020)

2. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (28th February 2020)

3. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study. (2019)

4. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (1st March 2020)

5. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (28th July 2019)

6. Lymph node imaging and correlation with histological N-class: results from the PROCLIPI study show sum of the product of dimensions is the better predictor than single axis measurements. (2019)

7. Primary cutaneous peripheral T‐cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico‐pathological and prognostic features. (22nd December 2020)

8. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*. (1st March 2021)

9. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. (10th September 2020)

10. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. (1st March 2021)